查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1362886

血栓管理设备市场规模、份额和趋势分析报告：按产品、最终用途、地区和细分趋势，2023-2030 年

Clot Management Devices Market Size, Share & Trends Analysis Report By Product (Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices), By End-use (Diagnostic Centers, Hospitals), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

血栓管理设备市场成长与趋势：

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球血栓管理设备市场规模预计将达到 25.3 亿美元，预测期内年复合成长率为 5.0%。

市场成长受到多种要素的推动，例如心血管疾病患病的增加、老年人口的增加以及医疗技术的进步。医疗专业人员和患者对有效血栓管理在预防严重健康併发症方面的好处的认识不断提高，也推动了对这些设备的需求。

心血管疾病罹患率的上升也刺激了市场需求。随着人口高龄化，与血栓形成相关的危险因子不断增加，凸显了有效解决方案的必要性。医疗保健提供者正在寻求先进的设备来解决日益增加的心血管疾病负担并降低凝血相关的风险。血栓管理设备的技术进步也推动了市场的成长。导管、过滤器和支架等创新技术正在开发中，以提高凝块回收和溶解能力。该领域最尖端科技的不断开拓正在推动采用率并推动市场成长。

COVID-19大流行对市场产生了强烈影响，提高了人们对与病毒相关的血液凝固风险增加的认识。医疗保健提供者越来越多地利用血块取出设备来治疗患有严重肺部病变和血栓相关併发症的COVID-19 患者，从而改善患者的治疗结果。提高对血栓管理重要性的认识可能会对优先考虑预防和管理凝血相关併发症的卫生系统产生长期影响。随着医疗保健提供者应对大流行带来的挑战并优先考虑全面的患者照护，市场预测持续成长。

血栓管理设备市场报告亮点

  • 从按产品来看，2022年经皮取栓设备的销售份额最大。这是因为它用于微创手术中去除血栓，这对患者和医疗保健提供者都有吸引力。此细分市场的主导地位也归功于技术进步，例如创新设备的开发和血栓清除效率的提高，导致对经皮血栓除去装置。
  • 根据最终用途，血栓管理设备市场分为诊断中心和医院。 2022 年，医院业务占收益占有率最大。该医院将作为需要血栓管理的患者的初级保健中心，提供初步评估、诊断和治疗建议。医院有专门的委员会和团队来选择医疗设备，并与价值链中的各个营业单位合作取得血栓管理设备。
  • 预计北美地区将在 2022 年以 59.73% 的最大收益占有率主导市场。北美拥有发达、先进的医疗基础设施，包括医院、诊所和医疗设施。此外，心血管疾病患病的上升和高龄化进一步推动了北美的产品需求。

目录

第1章调查方法和范围

第2章执行摘要

第3章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 市场趋势及展望
  • 市场动态
    • 心血管疾病患病增加
    • 医疗科技的进步
    • 有效血栓切除术/栓塞设备的需求增加
  • 市场抑制因素分析
    • 设备成本高
    • 意识和培训有限
  • 营商环境分析
    • SWOT 分析；要素因素（政治/法律、经济/技术）
    • 波特五力分析
  • COVID-19感染疾病的影响分析

第4章血栓管理设备市场：产品細項分析

  • 血栓管理设备：2022 年和 2030 年市场占有率分析
  • 神经血管栓塞装置
  • 用于清除栓塞的球囊导管
  • 经皮栓装置
  • 导管定向溶栓（CDT）装置
  • 大静脉筛检程式(IVCF)

第5章血栓管理设备市场：最终用途細項分析

  • 血栓管理设备：2022 年和 2030 年市场占有率分析
  • 诊断中心
  • 医院

第6章血栓管理设备市场：区域分析

  • 2022 年及 2030 年血栓管理设备市场占有率（按地区）
  • 北美洲
    • 北美血栓管理设备市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲血栓管理设备市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区血栓管理设备市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲血栓管理设备市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 2018-2030年中东及非洲血栓管理设备市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 公司分类
  • 策略规划
  • 2022 年公司市场占有率分析
  • 公司简介/名单
    • Medtronic
    • Boston Scientific Corporation
    • iVascular SLU
    • Teleflex Inc
    • Edwards Lifesciences Corporation
    • LeMaitre Vascular, Inc
    • Vascular Solutions, Inc
    • Straub Medical AG
    • Cook Medical
    • DePuy Synthes
Product Code: GVR-1-68038-201-3

Clot Management Devices Market Growth & Trends:

The global clot management devices market size is expected to reach USD 2.53 billion by 2030, advancing at a CAGR of 5.0% during the forecast period, according to a new report by Grand View Research, Inc.. The market growth is driven by several factors, including an increase in the prevalence of cardiovascular diseases, a rise in geriatric population, and advancements in medical technology. The demand for these devices is also fueled by the growth in awareness among healthcare professionals and patients regarding the benefits of effective clot management in preventing serious health complications.

The rising incidence of cardiovascular diseases has fueled market demand. As the population ages, the risk factors associated with blood coagulum formation increase, highlighting the need for effective solutions. Healthcare providers are seeking advanced devices to address the growing burden of CVDs and mitigate coagulum-related risks. Technological advancements in clot management devices have also driven market growth. Innovations such as catheters, filters, and stents are being developed to enhance coagulum retrieval and dissolution capabilities. Continued development of cutting-edge technologies in the field has boosted adoption rates and propelled market growth.

The COVID-19 pandemic strongly impacted the market by raising awareness of the increased blood coagulum risk associated with the virus. Healthcare providers have increasingly utilized clot retrieval devices to treat COVID-19 patients with severe lung involvement and clot-related complications, improving patient outcomes. Increased awareness of clot management's importance is poised to have long-lasting effects on healthcare systems prioritizing the prevention and management of coagulum-related complications. The market is poised to witness sustained growth as healthcare providers address challenges posed by the pandemic and prioritize comprehensive patient care.

Clot Management Devices Market Report Highlights:

  • Based on product, the percutaneous thrombectomy devices segment held the largest revenue share in 2022, as it is used in minimally invasive procedures for removing blood clots, which appeals to both patients and healthcare providers. The segment's dominance can also be attributed to advancements in technology, such as the development of innovative devices and improved efficacy in clot removal, leading to higher adoption rates and demand for percutaneous thrombectomy devices
  • Based on end-use, the market for clot management devices has been categorized into diagnostic centers and hospitals. The hospitals segment accounted for the largest revenue share in 2022. Hospitals serve as the primary point of care for patients requiring clot management, providing initial evaluation, diagnosis, and treatment recommendations. They have dedicated committees and teams for selecting medical devices and collaborating with different entities in the value chain to access clot management devices
  • The North American region accounted for the largest revenue share of 59.73% in 2022 and is expected to dominate the market. North America has a well-developed, advanced healthcare infrastructure, including hospitals, clinics, and medical facilities; additionally, the rising prevalence of cardiovascular diseases and an aging population further drive product demand in North America

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information Or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing Prevalence of cardiovascular diseases
    • 3.4.2. Advancements In Medical Technology
    • 3.4.3. Increasing Demand for Effective Thrombectomy/Embolectomy Devices
  • 3.5. Market Restraint Analysis
    • 3.5.1. High device cost
    • 3.5.2. Limited awareness and training
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Clot Management Devices Market: Product Segment Analysis

  • 4.1. Clot Management Devices: Market Share Analysis, 2022 & 2030
  • 4.2. Neurovascular Embolectomy Devices
    • 4.2.1. Neurovascular Embolectomy Devices Market, 2018 - 2030 (USD Million)
  • 4.3. Embolectomy Balloon Catheters
    • 4.3.1. Embolectomy Balloon Catheters Market, 2018 - 2030 (USD Million)
  • 4.4. Percutaneous Thrombectomy Devices
    • 4.4.1. Percutaneous Thrombectomy Devices Market, 2018 - 2030 (USD Million)
    • 4.4.2. Aspiration Thrombectomy Devices
      • 4.4.2.1. Aspiration Thrombectomy Devices market, 2018 - 2030 (USD Million)
    • 4.4.3. Percutaneous Mechanical Thrombectomy Devices
      • 4.4.3.1. Percutaneous Mechanical Thrombectomy Devices market, 2018 - 2030 (USD Million)
  • 4.5. Catheter-Directed Thrombolysis (CDT) Devices
    • 4.5.1. Catheter-Directed Thrombolysis (CDT) Devices Market, 2018 - 2030 (USD Million)
  • 4.6. Inferior Vena Cava Filters (IVCF)
    • 4.6.1. Inferior Vena Cava Filters (IVCF) MARKET, 2018 - 2030 (USD MILLION)

Chapter 5. Clot Management Devices Market: End-Use Segment Analysis

  • 5.1. Clot Management Devices: Market Share Analysis, 2022 & 2030
  • 5.2. Diagnostic Centers
    • 5.2.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market, 2018 - 2030 (USD Million)

Chapter 6. Clot Management Devices Market; Regional Analysis

  • 6.1. Clot Management Devices Market Share By Region, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Clot Management Devices Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Clot Management Devices Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Clot Management Devices Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Mexico Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Argentina Clot Management Devices Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Clot Management Devices Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Medtronic
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Boston Scientific Corporation
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. iVascular SLU
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Teleflex Inc
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Edwards Lifesciences Corporation
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. LeMaitre Vascular, Inc
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Vascular Solutions, Inc
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Straub Medical AG
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Cook Medical
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. DePuy Synthes
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 Global clot management devices market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 UK clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 UK clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Germany clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 18 Germany clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 France clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 France clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Italy clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Spain clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Spain clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Denmark clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 26 Denmark clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Sweden clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Sweden clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Norway clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Norway clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Japan clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 35 Japan clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 China clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 37 China clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 India clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 39 India clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Australia clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 41 Australia clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Thailand clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 43 Thailand clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 South Korea clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 45 South Korea clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Latin America clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 48 Latin America clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Brazil clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 50 Brazil clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Mexico clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 52 Mexico clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Africa clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 UAE clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait clot management devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 Clot management devices market segmentation
  • FIG. 8 Market snapshot, 2022
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Market penetration & growth prospect mapping, 2022
  • FIG. 15 Global clot management devices market: Product movement analysis
  • FIG. 16 Global clot management devices market, for neurovascular embolectomy devices, 2018 - 2030 (USD Million)
  • FIG. 17 Global clot management devices market, for embolectomy balloon catheters, 2018 - 2030 (USD Million)
  • FIG. 18 Global clot management devices market, for percutaneous thrombectomy devices, 2018 - 2030 (USD Million)
  • FIG. 19 Global clot management devices market, for catheter-directed thrombolysis (CDT) devices, 2018 - 2030 (USD Million)
  • FIG. 20 Global clot management devices market, for inferior vena cava filters (IVCF), 2018 - 2030 (USD Million)
  • FIG. 21 Global clot management devices market: End user movement analysis
  • FIG. 22 Global clot management devices market, for diagnostic centers, 2018 - 2030 (USD Million)
  • FIG. 23 Global clot management devices market, for hospitals, 2018 - 2030 (USD Million)
  • FIG. 24 Regional marketplace: Key takeaways
  • FIG. 25 Regional outlook, 2022 & 2030
  • FIG. 26 Global clot management devices market: Regional movement analysis
  • FIG. 27 North America clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 28 U.S. clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 29 Canada clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 30 Europe clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 31 Germany clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 32 UK clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 33 France clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 34 Italy clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 35 Spain clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 36 Denmark clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 37 Sweden clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 38 Norway clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 39 Asia Pacific clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 40 Japan clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 41 China clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 42 India clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 43 Australia clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 44 South Korea clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 45 Thailand clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 46 Latin America clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 47 Brazil clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 48 Mexico clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 49 Argentina clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 50 Middle East and Africa clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 51 South Africa clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 52 Saudi Arabia clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 53 UAE clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 54 Kuwait clot management devices market, 2018 - 2030 (USD Million)